Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CMV Infection and Immune Intervention After Haploidentical Hematopoietic Stem Cell Transplantation

NCT04320303 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT04320303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04320303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CMV Infection and Immune Intervention After Haploidentical Hematopoietic Stem Cell Transplantation
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 23, 2020
Completion date
December 31, 2021
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cmv viremia, transplantation infection